Drug intelligence / Profile preview

TVG Streptococcus suis vaccine

Development stage
Preclinical
Lead developer
TVG
Modality
Viral Vector Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
01

Overview

TVG Streptococcus suis vaccine is an experimental herpesvirus-based viral-vector vaccine being developed by The Vaccine Group (TVG) for the prevention of *Streptococcus suis* infection in pigs. The vaccine platform utilizes a herpesvirus vector to deliver and express specific *Streptococcus suis* antigens, which triggers a protective immune response in the host. In preclinical studies, the vaccine has demonstrated cross-serotype protection in piglets and has shown efficacy superior to currently available commercial vaccines. *Streptococcus suis* is a significant swine pathogen that causes various conditions including meningitis, septicemia, and arthritis, and also poses a zoonotic risk to humans.

Other names
Streptococcus suis vaccineTVG-Streptococcus suis antigen-herpesvirus-based viral-vector vaccine-Streptococcus suis infection in pigs
02

Targets

Streptococcus suis IgM protease and related Streptococcus suis antigens

Beyond the preview

Go deeper on TVG Streptococcus suis vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TVG Streptococcus suis vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call